...
首页> 外文期刊>Journal of Thoracic Disease >Pulmonary function tests findings and their diagnostic value in patients with IgG4-related disease
【24h】

Pulmonary function tests findings and their diagnostic value in patients with IgG4-related disease

机译:IgG4相关疾病患者的肺功能测试结果及其诊断价值

获取原文
           

摘要

Background: IgG4-related disease (IgG4-RD) is an immune-mediated fibroinflammatory disorder that can affect most organs. To date, there have been no detailed assessments of pulmonary function in patients with IgG4-RD. In this study, we investigated pulmonary function in IgG4-RD patients and evaluated the value of pulmonary function tests (PFTs) in diagnosing IgG4-related respiratory disease (IgG4-RRD). Methods: This was a retrospective study of 17 patients with IgG4-RD. The patients were divided into two groups: IgG4-RRD group and IgG4-related disease extrapulmonary involvement (IgG4-RDEI) group. The PFT results were compared between the two groups. Results: All patients in the IgG4-RRD group had pulmonary dysfunction. Five of 8 (62.5%) patients in the IgG4-RDEI group had pulmonary dysfunction, despite having normal thoracic computed tomography scans and no respiratory symptoms. Patients in both groups showed restrictive ventilatory dysfunction and abnormal diffusing capacity, and two patients in the IgG4-RRD group had obstructive ventilatory dysfunction. The incidence of diffusing capacity of the lung for carbon monoxide per liter of alveolar volume (D L CO/V A ) decrease were significantly higher in the IgG4-RRD group than in the IgG4-RDEI group (P=0.029).D L CO/V A were significantly higher in the IgG4-RDEI than in the IgG4-RRD group (P=0.044), but otherwise, there were no significant differences. We report the first finding of a negative correlation between pulmonary diffusing capacity and total serum concentrations of IgG and IgG subclasses (IgG4, IgG3 and IgG2). Conclusions: D L CO/V A plays an important role for detecting lung involvement in IgG4-RD patients. The patient with high serum IgG may be more prone to respiratory involvement.
机译:背景:IgG4相关疾病(IgG4-RD)是一种免疫介导的纤维炎性疾病,可影响大多数器官。迄今为止,尚未对IgG4-RD患者的肺功能进行详细评估。在这项研究中,我们调查了IgG4-RD患者的肺功能,并评估了肺功能测试(PFT)在诊断与IgG4相关的呼吸系统疾病(IgG4-RRD)中的价值。方法:这是对17例IgG4-RD患者的回顾性研究。将患者分为两组:IgG4-RRD组和IgG4相关疾病肺外受累(IgG4-RDEI)组。比较了两组的PFT结果。结果:IgG4-RRD组的所有患者均患有肺功能障碍。 IgG4-RDEI组的8例患者中有5例(62.5%)尽管胸部计算机断层扫描正常且无呼吸症状,但仍存在肺功能障碍。两组患者均显示出限制性通气功能障碍和弥散能力异常,IgG4-RRD组中有2例患者出现阻塞性通气功能障碍。与IgG4-RDEI组相比,IgG4-RRD组每升肺泡体积肺扩散能力降低的发生率(DL CO / VA)明显高于IgG4-RDEI组(P = 0.029)。 IgG4-RDEI组的IgG4显着高于IgG4-RRD组的(P = 0.044),但除此之外没有显着差异。我们报告了肺扩散能力与IgG和IgG亚类(IgG4,IgG3和IgG2)的总血清浓度之间负相关的第一个发现。结论:D L CO / VA在检测IgG4-RD患者肺部受累中起重要作用。血清IgG高的患者可能更容易呼吸系统受累。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号